160 related articles for article (PubMed ID: 3595703)
1. Concentration of azapropazone in synovial tissues and fluid.
Spahn H; Thabe K; Mutschler E; Tillmann K; Gikalov I
Eur J Clin Pharmacol; 1987; 32(3):303-7. PubMed ID: 3595703
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of azapropazone following single oral and intravenous doses.
Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of azapropazone in the elderly.
Ritch AE; Perera WN; Jones CJ
Br J Clin Pharmacol; 1982 Jul; 14(1):116-9. PubMed ID: 7104163
[TBL] [Abstract][Full Text] [Related]
4. Ibuprofen kinetics in plasma and synovial fluid of arthritic patients.
Gallo JM; Gall EP; Gillespie WR; Albert KS; Perrier D
J Clin Pharmacol; 1986 Jan; 26(1):65-70. PubMed ID: 3950052
[TBL] [Abstract][Full Text] [Related]
5. [Synovial tissue levels in comparison with synovial fluid and serum concentrations following a single daily administration of 20 mg piroxicam (Felden)].
Thabe H; Fassbender HG; Laufen H; Gierend M
Z Rheumatol; 1986; 45(5):271-6. PubMed ID: 3811635
[TBL] [Abstract][Full Text] [Related]
6. Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.
Aarons L; Salisbury R; Alam-Siddiqi M; Taylor L; Grennan DM
Br J Clin Pharmacol; 1986 Feb; 21(2):155-63. PubMed ID: 3954931
[TBL] [Abstract][Full Text] [Related]
7. [Human pharmacokinetics of different i.v. doses of azapropazone (HPLC-determination) (author's transl)].
Gikalov I; Kaufmann R; Schuster O
Arzneimittelforschung; 1982; 32(4):423-6. PubMed ID: 7201814
[TBL] [Abstract][Full Text] [Related]
8. [Azapropazone plasma levels under simultaneous treatment with an antacid or laxative].
Faust-Tinnefeldt G; Geissler HE; Mutschler E
Arzneimittelforschung; 1977; 27(12):2411-4. PubMed ID: 580058
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of surfactant proteins A, B, C, and D in articular cartilage, synovial membrane and synovial fluid of healthy as well as patients with osteoarthritis and rheumatoid arthritis.
Hartjen N; Bräuer L; Reiß B; Claassen H; Beileke S; Garreis F; Hoogeboom S; Tsokos M; Etzold S; Müller-Hilke B; Gelse K; Müller T; Goldring MB; Paulsen F; Schicht M
PLoS One; 2018; 13(9):e0203502. PubMed ID: 30235245
[TBL] [Abstract][Full Text] [Related]
10. Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.
Farr M; Brodrick A; Bacon PA
Rheumatol Int; 1985; 5(6):247-51. PubMed ID: 2906452
[TBL] [Abstract][Full Text] [Related]
11. The determination of azapropazone in blood plasma.
Leach H
Curr Med Res Opin; 1976; 4(1):35-43. PubMed ID: 1261300
[TBL] [Abstract][Full Text] [Related]
12. Distribution of azapropazone and its principal 8-hydroxy-metabolite in plasma, urine and gastrointestinal mucosa determined by HPLC.
Rainsford KD
J Pharm Pharmacol; 1985 May; 37(5):341-5. PubMed ID: 2862244
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of azapropazone and indomethacin in the treatment of rheumatoid arthritis.
Thune S
Curr Med Res Opin; 1976; 4(1):70-5. PubMed ID: 770083
[TBL] [Abstract][Full Text] [Related]
14. [Azapropazone plasma levels in rheumatologic therapy with D-penicillamine combined with immunosuppressive agents].
Faust-Tinnefeldt G; Geissler HE; Mutschler E
Arzneimittelforschung; 1977; 27(11):2153-7. PubMed ID: 580020
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
[TBL] [Abstract][Full Text] [Related]
16. [Biochemical shifts in the synovial system, muscles and blood in rheumatoid arthritis].
Guobis G; Panavene D; Bandzhiulene S; Staponas A
Vopr Revm; 1981; (1):31-4. PubMed ID: 7222537
[No Abstract] [Full Text] [Related]
17. [Azapropazone and rheumatic combination therapy considering drug interactions: azapropazone aurothioglucose and azapropazone prednisolone].
Faust-Tinnefeldt GF; Geissler HE
Arzneimittelforschung; 1978; 28(2):337-41. PubMed ID: 346022
[No Abstract] [Full Text] [Related]
18. Fibronectin in plasma and synovial fluid of patients with rheumatic diseases.
Duţu A; Vlaicu-Rus V; Boloşiu HD; Parasca I; Cristea A
Med Interne; 1986; 24(1):61-8. PubMed ID: 3518030
[TBL] [Abstract][Full Text] [Related]
19. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis.
Menkes CJ; Renoux M; Laoussadi S; Mauborgne A; Bruxelle J; Cesselin F
J Rheumatol; 1993 Apr; 20(4):714-7. PubMed ID: 7684449
[TBL] [Abstract][Full Text] [Related]
20. [A study of opioid peptides in synovial fluid and synovial tissue in patients with rheumatoid arthritis].
Suzuki N; Yoshino S; Nakamura H
Arerugi; 1992 May; 41(5):615-20. PubMed ID: 1520070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
